EKF EKF Diagnostics Holdings plc

LSE · GB · Healthcare · Medical Devices · ekfdiagnostics.com

24.10GBp-2.03%Mkt Cap: 112.11M $P/E: 24.10Today

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and interna…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap112.11M USD

Enterprise Value100.61M USD

Revenue (TTM)55.82M USD

Gross Profit28.78M USD

Net Income (TTM)2.31M USD

Revenue/Share0.12 GBp

Last Price24.10 GBp

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees308

CountryGB

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)24.10

P/E (Forward)13.35

PEG—

EV/EBITDA9.09

EV/Revenue1.80

P/S2.05

P/B1.50

EPS (TTM)0.01

EPS (Forward)0.02

52W Range

0.000076% of range31.80

52W High31.80 GBp

52W Low0.0000 GBp

Profitability

Gross Margin51.35%

Oper. Margin14.44%

EBITDA Margin19.82%

Profit Margin4.12%

ROE3.07%

ROA2.62%

Growth

Revenue Growth-0.80%

Earnings Growth25.20%

Cash Flow & Leverage

Operating CF10.55M USD

CapEx (TTM)2.57M USD

FCF Margin9.83%

FCF Yield4.89%

Net Debt-15.76M USD

Net Debt/EBITDA-1.42

Balance Sheet

Debt/Equity0.02

Current Ratio4.71

Quick Ratio3.38

Book Value/Sh0.16 GBp

Cash/Share0.04 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 GBp

Div. Yield0.00%

5Y Avg Yield2.48%

Payout Ratio0.00%

Ex-Div DateNov 2, 2023

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)34.67 GBp

Upside (mean)+43.8%

Target Range34.00 GBp – 35.00 GBp

34.00+43.8% to mean35.00

# Analysts3

Ownership

Shares Out.427.97M

Float352.22M

Insiders3.94%

Institutions72.77%

Technical

SMA 5025.33 (-4.8%)

SMA 20025.63 (-6.0%)

Beta0.50

S&P 52W Chg14.58%

Avg Vol (30d)594.13K

Avg Vol (10d)388.77K

Technical Indicators

RSI (14)44.1

MACD-0.2068

MACD Signal-0.1279

MACD Hist.-0.0789

BB Upper26.20 GBp

BB Middle25.22 GBp

BB Lower24.24 GBp

BB Width7.78%

ATR (14)1.056 GBp

Vol Ratio (20d)0.02x